Treasury Yield Surge Challenges RiskFree Status Opens Opportunities in Intermediates and Credit Markets Mercury Hits 52 Billion Valuation After 200 Million Funding Round Surging 49 in 14 Months Veradermics MANE Emerges as a Top Performer on NYSE in Early 2026 CapitaLands 14 Billion Geneo Hub Aims to Strengthen Singapores Life Sciences Ecosystem Analysts Highlight Vistra Corp as Potential AIDriven Energy Stock Foreign Investors Snap Up Japanese Stocks for Eighth Consecutive Week Amid AIDriven Rally MWA Q1 2026 Earnings EPS Beats Estimates by 647 IHS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Macro Environment SIGI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Underwriting Environment Aurora Innovation Q1 2026 Earnings EPS Beat Masks PreRevenue Reality Amid Ongoing Development Costs CV Q1 2026 Earnings EPS Misses Estimates as Company Reports Wider Loss OFS Capital Corporation OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Net Investment Income Micropolis AI Robotics MCRP Gains 558 as Investors Eye Key Resistance Levels Endava DAVA Holds Steady Near Support Amid Modest Pullback JOYY Inc JOYY Posts 212 Advance as Stock Approaches Key Resistance Zone STAK Inc STAK Slides Toward Key Support After 455 Decline Liquidia Corporation LQDA Gains 32 as Biotech Momentum Builds Key Levels Ahead Kevin Warsh Takes Over as Fed Chair Pledges ReformOriented Agenda at White House Ceremony NEWTI Q1 2026 Earnings EPS Misses Expectations Amid Flat Revenue Telesat TSAT Edges Higher Amidst Consolidation Near Key Resistance CCM Q2 2016 Earnings Significant EPS Miss as Company Reports WiderThanExpected Loss FICO Q1 2026 Earnings EPS Surges Past Estimates as Profitability Shines JCTC Q3 2025 Earnings Narrowing Loss and Positive Market Response Despite Revenue Uncertainty UMBFO Q1 2026 Earnings Strong EPS Beat Signals Resilience Despite Revenue Disclosure Gap Intercorp Financial Services Inc IFS Q1 2026 Earnings EPS Surprise Lifts Results Despite Tepid Stock Reaction PLTR Q1 2026 Earnings EPS Surges Past Estimates but Stock Declines Immunome Inc IMNM Q1 2026 Earnings SmallerThanExpected Loss as Biotech Advances Pipeline